FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness
[11/1/2024] FDA is warning patients and health care professionals not to use drugs compounded and distributed...
FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns
[9/26/2024] FDA is alerting patients, caregivers, and health care professionals that Oxbryta (voxelotor)...
Colorectal cancer: Immunotherapy drug may help patients avoid surgery
Share on PinterestThe immunotherapy drug pembrolizumab could increase cancer-free outcomes for some patients...
AFib: Study finds RF-based ablations stopped symptoms in most patients
Share on PinterestA new study found that ablation is an effective treatment for AFib in most patients....
Wegovy patients maintained weight loss for 4 years, analysis shows
Share on PinterestA new study finds the benefits of Wegovy for diabetes, heart disease, and weight loss...
FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs
[11-8-2022] Health care professionals should be cautious of possible xylazine inclusion in fentanyl,...
FDA alerts patients, caregivers, and health care providers of cross-compatibility issues with autoinjector devices that are optional for use with glatiramer acetate injection
[8/18/2022] FDA is alerting patients, caregivers, and health care professionals that autoinjector devices...
FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding
[5/25/2022] FDA is alerting customers of North American Custom Laboratories LLC, doing business as FarmaKeio...
FDA alerts patients and health care professionals not to use compounded products intended to be sterile from Prescription Labs Inc. dba Greenpark Compounding Pharmacy
[9/29/2021] Update: FDA is alerting veterinarians and animal owners/caretakers not to use compounded...
FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)
[7/28/2021] FDA is alerting patients and Health care professionals that a clinical trial (OCEAN, Study...
FDA alerts patients and health care professionals of Amneal and Impax Laboratories epinephrine auto-injector device malfunctions
[6/1/2020] FDA is alerting patients, caregivers and health care professionals to immediately inspect...
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration
Update [4/9/2020] FDA is notifying patients and caregivers that EpiPens are not being recalled at this...
FDA advises patients not to use Herbal Doctor Remedies’ medicines
[4/1/2020] FDA reminds patients not to use any drugs manufactured by Herbal Doctor Remedies, Monterey...
FDA alerts patients and healthcare professionals to Infusion Options’ voluntary recall due to quality issues
[6/21/2019] The U.S. Food and Drug Administration is alerting Healthcare professionals and patients of...
FDA alerts patients of McDaniel Life-Line’s voluntary recall of Indian Herb
Update [3/29/19] FDA is alerting health care professionals and patients of McDaniel Life-Line’s voluntarily...
FDA alerts health care professionals and patients not to use drug products intended to be sterile from Promise Pharmacy
Compounded drugs were produced under poor sterile production practices in an inadequately designed processing...
FDA alerts health care professionals and patients not to use sterile drug products from Pharm D Solutions
[11/19/2018] The U.S. Food and Drug Administration is alerting Health care professionals and patients...
FDA alerts patients and health care professionals that some EpiPen auto-injectors may not readily slide out of carrier tube
[11/2/2018] FDA is alerting patients, caregivers and Health care professionals that the labels attached...